David Lamond is of Cortexyme, Inc.. Currently has a direct ownership of 2.3 Million shares of CRTX, which is worth approximately $2.97 Million. The most recent transaction as insider was on Dec 12, 2023, when has been sold 22,327 shares (Common Stock) at a price of $1.02 per share, resulting in proceeds of $22,773. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.3M
0% 3M change
n/a 12M change
Total Value Held $2.97 Million

David Lamond Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2023
BUY
Open market or private purchase
$22,773 $1.02 p/Share
22,327 Added 0.96%
2,302,291 Common Stock

Also insider at

LHDX
Lucira Health, Inc. Healthcare
AMTI
Applied Molecular Transport Inc. Healthcare
DL

David Lamond

Emeryville, CA

Track Institutional and Insider Activities on CRTX

Follow Cortexyme, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRTX shares.

Notify only if

Insider Trading

Get notified when an Cortexyme, Inc. insider buys or sells CRTX shares.

Notify only if

News

Receive news related to Cortexyme, Inc.

Track Activities on CRTX